Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
Certara, Inc., a global leader in biosimulation, announced the introduction of Simcyp™ Biopharmaceutics software. It is designed for use by biopharmaceutic, formulation, and CMC scientists to aid in formulating complex novel and generic small...
BeiGene, Ltd., a global biotechnology company, and Ensem Therapeutics, Inc. (ENSEM), a biotechnology company focusing on high-value and difficult-to-drug oncology targets, announced an agreement for BeiGene to acquire an exclusive global license to an Investigational New Drug (IND) application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor.
“We are committed to developing...
Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies
Genentech, a member of the Roche Group, announced a multi-year strategic research collaboration with NVIDIA that couples Genentech’s artificial intelligence (AI) capabilities, extensive...
Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announce that they have entered...
New Advisory Brief Discusses Four Pillars to Focus Resource Allocation, Improve Patient Care and Provide Differentiated Patient Partnership
Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief...
Evinova's globally scaled digital healthcare solutions are evidence-based, science-based and human-experience-based, serving clinical trial sponsors, clinical research organizations (CROs), clinical trial site care teams and patients.
AstraZeneca launched Evinova, which aims to become a leading provider of digital healthcare solutions to better meet the needs of healthcare professionals, regulators and...
New solutions empower clinicians and research teams with AI orchestration, model development, visualization, and multi-modal data management to power clinical research, clinical trials, and patient care strategies.
ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to its AI partner ecosystem to...
Cofactor Genomics, the company bridging the precision medicine gap, announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma of the head and neck (HNSCC). The successful readout is...
TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce that its innovative Product Availability Intelligence (PAI) solution has been recognized with a Bronze award by the prestigious Merit...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced the addition of Lucida Medical to its Eureka Clinical AI Platform ecosystem. It will be deployed within the UK's National Health Service (NHS) and European healthcare systems.
Pi™ (Prostate Intelligence™), Lucida Medical's AI-machine learning software, is designed to help...
